炎症性肠病手术出院后静脉血栓栓塞风险计算器
本研究基于美国外科医师学会国家手术质量改进计划2012至2018年炎症性肠病手术患者数据,识别出院后静脉血栓栓塞的相关因素,并构建风险计算器。18,990例患者中199例(1.1%)在术后30天内发生出院后静脉血栓栓塞,预测概率范围为0.2%至14.3%。该计算器可用于个体化制定延长静脉血栓栓塞药物预防方案。
要点
- 出院后静脉血栓栓塞发生率为1.1%,预测概率范围0.2%–14.3%。
- 术前因素包括BMI≥35、使用类固醇、溃疡性结肠炎。
- 术后因素包括吻合口漏和肠梗阻,微创手术亦与风险相关。
核心结论
- 术前、术中及术后因素均与炎症性肠病手术出院后静脉血栓栓塞相关。
- 已开发出院后静脉血栓栓塞风险计算器,可依据个体风险调整延长药物预防。
研究设计与样本
- 回顾性队列研究,数据来自美国外科医师学会国家手术质量改进计划2012至2018年结肠切除和直肠切除目标模块。
- 共纳入18,990例因炎症性肠病行结直肠切除的患者。
- 采用多变量逻辑回归分析患者及手术因素与出院后静脉血栓栓塞的关联,并构建风险计算器。
主要发现
- 199例(1.1%)在术后30天内发生出院后静脉血栓栓塞。
- BMI≥35者发生率为1.9%,BMI 18.5-24.9者为0.8%(OR 2.34,95%CI 1.49-3.67)。
- 使用类固醇者发生率为1.3%,未使用者为0.7%(OR 1.91,95%CI 1.37-2.66)。
- 溃疡性结肠炎患者发生率为1.5%,克罗恩病者为0.8%(OR 1.76,95%CI 1.32-2.34)。
- 微创手术发生率为1.2%,开放手术为0.9%(OR 1.42,95%CI 1.05-1.92);吻合口漏发生率为2.8% vs 1.0%(OR 2.24,95%CI 1.31-3.83);肠梗阻为2.1% vs 0.9%(OR 2.60,95%CI 1.91-3.54)。
临床怎么用
- 可使用该风险计算器评估炎症性肠病手术患者出院后静脉血栓栓塞的个体化风险。
- 根据计算器得出的预测概率,个体化决定是否延长静脉血栓栓塞药物预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines recommend extended chemoprophylaxis for venous thromboembolism in high-risk patients having operations for inflammatory bowel disease. Quantifying patients' risk of venous thromboembolism, however, remains challenging. We sought (1) to identify factors associated with postdischarge venous thromboembolism in patients undergoing colorectal resection for inflammatory bowel disease and (2) to develop a postdischarge venous thromboembolism risk calculator to guide prescribing of extended chemoprophylaxis. METHODS: Patients who underwent an operation for inflammatory bowel disease from 2012 to 2018 were identified from the American College of Surgeons National Surgical Quality Improvement Program for colectomy and proctectomy procedure targeted modules. Postdischarge venous thromboembolism included pulmonary embolism or deep vein thrombosis diagnosed after discharge from the index hospitalization. Multivariable logistic regression estimated the association of patient/operative factors with postdischarge venous thromboembolism. A postdischarge venous thromboembolism risk calculator was subsequently constructed. RESULTS: Of 18,990 patients, 199 (1.1%) developed a postdischarge venous thromboembolism within the first 30 postoperative days. Preoperative factors associated with postdischarge venous thromboembolism included body mass index (1.9% with body mass index ≥35 vs 0.8% with body mass index 18.5-24.9; odds ratio 2.34 [95% confidence interval 1.49-3.67]), steroid use (1.3% vs 0.7%; odds ratio 1.91 [95% confidence interval 1.37-2.66]), and ulcerative colitis (1.5% vs 0.8% with Crohn's disease; odds ratio 1.76 [95% confidence interval 1.32-2.34]). Minimally invasive surgery was associated with postdischarge venous thromboembolism (1.2% vs 0.9% with open; odds ratio 1.42 [95% confidence interval 1.05-1.92]), as was anastomotic leak (2.8% vs 1.0%; odds ratio 2.24 [95% confidence interval 1.31-3.83]) and ileus (2.1% vs 0.9%; odds ratio 2.60 [95% confidence interval 1.91-3.54]). The predicted probability of postdischarge venous thromboembolism ranged from 0.2% to 14.3% based on individual risk factors. CONCLUSION: Preoperative, intraoperative, and postoperative factors are associated with postdischarge venous thromboembolism after an operation for inflammatory bowel disease. A postdischarge venous thromboembolism risk calculator was developed which can be used to tailor extended venous thromboembolism chemoprophylaxis by individual risk.
引用
- Schlick CJR, Yuce TK, Yang AD, et al. A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery. Surgery. 2020. PMID: 33077197. doi:10.1016/j.surg.2020.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。